EGFR and KRAS mutations detection on lung cancer liquid-based cytology: A pilot study

Journal of Clinical Pathology

Volumn 65, Issue 1, 2012, Pages 87-91

  Malapelle, Umberto ^a   De Rosa, Nicla ^b   Rocco, Danilo ^b   Bellevicine, Claudio ^a   Crispino, Carlo ^b   Illiano, Alfonso ^b   Piantedosi, Franco Vito ^b   Nappi, Oscar ^c   Troncone, Giancarlo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b AORN Vincenzo Mondaldi   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CELL DENSITY; CLINICAL ARTICLE; DNA EXTRACTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LIQUID BASED CYTOLOGY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MALE; MUTATIONAL ANALYSIS; PAPANICOLAOU TEST; PILOT STUDY; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; ITALY; LASER CAPTURE MICRODISSECTION; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; TUMOR MARKERS, BIOLOGICAL;

EID: 84355162192     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200296     Document Type: Article

References (12)

1. Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med 2008;358:1160-74.
2. Malapelle U, Bellevicine C, Zeppa P, et al. Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy: a review. Diagn Cytopathol. Published Online First: 9 November 2010. doi:10.1002/dc.21512.
3. Fassina A, Gazziero A, Zardo D, et al. Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis. J Clin Pathol 2009;62:1096-102.
4. Natu S, Hoffman J, Siddiqui M, et al. The role of endobronchial ultrasound guided transbronchial needle aspiration cytology in the investigation of mediastinal lymphadenopathy and masses, the North Tees experience. J Clin Pathol 2010;63:445-51.
5. Lee YS, Jin GY, Han YM, et al. Computed tomography-guided transthoracic needle aspiration biopsy of intrapulmonary lesions: utility of a liquid-based cytopreparatory technique. Acta Cytol 2008;52:665-70.
6. Boldrini L, Gisfredi S, Ursino S, et al. Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis. J Thorac Oncol 2007;2:1086-90. (Pubitemid 350307900)
7. Smouse JH, Cibas ES, Janne PA, et al. EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer. Cancer 2009;117:67-72.
8. Molina-Vila MA, Bertran-Alamillo J, Reguart N, et al. Queralt C and others. A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells. J Thorac Oncol 2008;3:1224-35.
9. Savic S, Tapia C, Grilli B, et al. Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers. Br J Cancer 2008;98:154-60.
10. Malapelle U, Bellevicine C, Russo A, et al. KRAS testing on colo-rectal carcinoma cytological imprints. Diagn Cytopathol 2011;39:274-7.
11. Rosell R, Moran T, Queralt C, et al. Provencio M and others. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009;361:958-67.
12. Billah S, Stewart J, Staerkel G, et al. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens. Cancer Cytopathol 2009;119:111-17.